ZA200106413B - T Helper cell epitopes. - Google Patents

T Helper cell epitopes.

Info

Publication number
ZA200106413B
ZA200106413B ZA200106413A ZA200106413A ZA200106413B ZA 200106413 B ZA200106413 B ZA 200106413B ZA 200106413 A ZA200106413 A ZA 200106413A ZA 200106413 A ZA200106413 A ZA 200106413A ZA 200106413 B ZA200106413 B ZA 200106413B
Authority
ZA
South Africa
Prior art keywords
epitopes
helper cell
cell epitopes
sgrrqrrfagvvlagva
fagvvlagvalgvataa
Prior art date
Application number
ZA200106413A
Inventor
David Charles Jackson
Souravi Ghosh
John Walker
Original Assignee
Univ Melbourne
Csl Ltd
Commw Scient Ind Res Org
Queensland Inst Med Res
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP8533A external-priority patent/AUPP853399A0/en
Priority claimed from AUPQ2013A external-priority patent/AUPQ201399A0/en
Application filed by Univ Melbourne, Csl Ltd, Commw Scient Ind Res Org, Queensland Inst Med Res, Inst Medical W & E Hall filed Critical Univ Melbourne
Publication of ZA200106413B publication Critical patent/ZA200106413B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Luminescent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

The present invention provides T helper cell epitopes and compositions for use in inducing an immune response comprising at least one of these epitopes. The epitopes are contained within a peptide sequence selected from the group consisting of SSKTQTHTQQDRPPQPS; QPSTELEETRTSRARHS; RHSTTSAQRSTHYDPRT; PRTSDRPVSYTMNRTRS; TRSRKQTSHRLKNIPVH; SHQYLVIKLIPNASLIE; IGTDNVHYKIMTRPSHQ; YKIMTRPSHQYLVIKLI; KLIPNASLIENCTKAEL; AELGEYEKLLNSVLEPI; KLLNSVLEPINQALTLM; EPINQALTLMTKNVKPL; FAGVVLAGVALGVATAA; GVALGVATAAQITAGIA; TAAQITAGIALHQSNLN; GIALHQSNLNAQAIQSL; NLNAQAIQSLRTSLEQS; QSLRTSLEQSNKAIEEI; EQSNKAIEEIREATQET; TELLSIFGPSLRDPISA; PRYIATNGYLISNFDES; CIRGDTSSCARTLVSGT; DESSCVFVSESAICSQN; TSTIINQSPDKLLTFIA, SPDKLLTFIASDTCPLV and SGRRQRRFAGVVLAGVA
ZA200106413A 1999-02-05 2001-08-03 T Helper cell epitopes. ZA200106413B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP8533A AUPP853399A0 (en) 1999-02-05 1999-02-05 T helper cell epitopes
AUPQ2013A AUPQ201399A0 (en) 1999-08-04 1999-08-04 T-helper cell epitopes

Publications (1)

Publication Number Publication Date
ZA200106413B true ZA200106413B (en) 2002-08-05

Family

ID=25645983

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200106413A ZA200106413B (en) 1999-02-05 2001-08-03 T Helper cell epitopes.

Country Status (15)

Country Link
US (5) US6685947B1 (en)
EP (2) EP1147212B1 (en)
JP (2) JP4699612B2 (en)
KR (2) KR100905264B1 (en)
AT (1) ATE440960T1 (en)
AU (1) AU765164B2 (en)
CA (1) CA2361658C (en)
CY (1) CY1109710T1 (en)
DE (1) DE60042816D1 (en)
DK (1) DK1147212T3 (en)
ES (1) ES2332701T3 (en)
NZ (1) NZ513482A (en)
PT (1) PT1147212E (en)
WO (1) WO2000046390A1 (en)
ZA (1) ZA200106413B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1147212B1 (en) * 1999-02-05 2009-08-26 The University Of Melbourne T helper cell epitopes
US20050106137A1 (en) * 2000-05-05 2005-05-19 Stephen Grimes Chimeric peptide immunogens
US20030045467A1 (en) * 2001-01-05 2003-03-06 Tihamer Orban Autoantigen composition
EP1543039B1 (en) 2002-08-12 2011-07-13 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes
AU2003249778B2 (en) 2002-08-12 2010-09-23 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
US7178491B2 (en) * 2003-06-05 2007-02-20 Caterpillar Inc Control system and method for engine valve actuator
AU2005265182B2 (en) * 2004-06-17 2012-06-21 Mannkind Corporation Epitope analogs
AU2005282231B2 (en) * 2004-09-10 2011-03-10 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated LHRH formulations
MX2007002930A (en) 2004-09-10 2007-10-15 Queensland Inst Med Res Truncated lhrh formulations.
US20090214598A1 (en) 2005-04-19 2009-08-27 Eli Lilly And Company Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
AU2006253914A1 (en) * 2005-06-01 2006-12-07 Pfizer Products Inc. Vaccine compositions and methods for the treatment of urinary incontinence
EP2385060A3 (en) 2005-06-17 2012-02-15 Mannkind Corporation Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
EP2371851A3 (en) * 2005-06-17 2012-08-01 Mannkind Corporation Epitope analogues
WO2007127787A2 (en) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Insulin autoantigen-specific regulatory cd4+ t cells
CO2021017322A1 (en) * 2021-12-16 2023-06-20 Univ Cooperativa De Colombia Immunogenic peptides against canine distemper virus (cdv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
JP2001513120A (en) 1997-02-11 2001-08-28 ザ カウンシル オブ ザ クイーンズランド インスティチュート オブ メディカル リサーチ Polymer containing peptide
EP1147212B1 (en) * 1999-02-05 2009-08-26 The University Of Melbourne T helper cell epitopes

Also Published As

Publication number Publication date
AU2783600A (en) 2000-08-25
JP4699612B2 (en) 2011-06-15
US7241448B2 (en) 2007-07-10
DK1147212T3 (en) 2010-01-04
WO2000046390A1 (en) 2000-08-10
US20070248615A1 (en) 2007-10-25
US6685947B1 (en) 2004-02-03
US20050186220A1 (en) 2005-08-25
ES2332701T3 (en) 2010-02-11
PT1147212E (en) 2009-12-03
US7572454B2 (en) 2009-08-11
CA2361658C (en) 2013-04-09
KR100955668B1 (en) 2010-05-06
DE60042816D1 (en) 2009-10-08
KR20090015892A (en) 2009-02-12
ATE440960T1 (en) 2009-09-15
KR100905264B1 (en) 2009-06-29
EP1147212A4 (en) 2004-03-31
EP1147212B1 (en) 2009-08-26
CY1109710T1 (en) 2014-08-13
EP1147212A1 (en) 2001-10-24
US20060199177A1 (en) 2006-09-07
JP2002536384A (en) 2002-10-29
KR20010101796A (en) 2001-11-14
US20050037014A1 (en) 2005-02-17
US7097844B2 (en) 2006-08-29
JP2011121965A (en) 2011-06-23
CA2361658A1 (en) 2000-08-10
AU765164B2 (en) 2003-09-11
US7037507B2 (en) 2006-05-02
EP2103691A1 (en) 2009-09-23
NZ513482A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
ZA200106413B (en) T Helper cell epitopes.
TR199900267T2 (en) GnRH-L�kotoksin kimeralar�.
NZ508366A (en) Neisseria meningitidis antigens and compositions
ATE244573T1 (en) CYCLOSPORINE CONTAINING MICROEMULSION PRECONCENTRATE COMPOSITION
PL345541A1 (en) Antigenic peptides derived from telomerase
ZA993938B (en) Ziprasidone formulations.
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
WO2002053180A3 (en) Immunizing compositions and methods of use
TR200000152T2 (en) New compounds.
ZA976815B (en) Vaccine composition.
GB2301591A (en) Cytotoxic T-cell epitopes
EP0652258A3 (en) Silicone release compositions.
MXPA03010684A (en) Peptides and the use thereof in darkening the skin.
GB0027088D0 (en) DNA expression vectors
ZA9811276B (en) Non-whitening underarm compositions.
HK1020739A1 (en) Novel lantibiotic related to actagardine, and processes for the preparation and use thereof.
IL139604A0 (en) Novel peptides
ZA985135B (en) Plant grab proteins.
HUP9802587A3 (en) Glucose-inducible recombinant viral vector, pharmaceutical composition containing it and cells transformed by this
ATE372787T1 (en) GENE COMPOSITIONS CONTAINING ATELOCOLLAGEN
SG185137A1 (en) Biologically active peptides
WO2001011937A3 (en) Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
ZA992262B (en) Vectors for transferring nucleic acids, compositions containing them and their uses.
ZA978477B (en) Cysteine containing peptides.
Reinhart The regime of lies